Profile data is unavailable for this security.
About the company
CellSource Co., Ltd. is a Japan-based company engaged in regenerative medicine related business and consumer business. The Company operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and regulations related to safety assurance such as regenerative medicine, as well as sales of medical equipment. The Consumer business segment is engaged in the sales of cosmetics and facial products to general consumers.
- Revenue in JPY (TTM)4.45bn
- Net income in JPY622.21m
- Incorporated2015
- Employees151.00
- LocationCellSource Co Ltd11F, Shibuya Cast, 1-23-21, ShibuyaSHIBUYA-KU 150-0002JapanJPN
- Phone+81 364555308
- Fax+81 364555968
- Websitehttps://www.cellsource.co.jp/
More ▼
10.21%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baillie Gifford & Co.as of 30 Sep 2024 | 524.90k | 2.65% |
| Nomura Asset Management Co., Ltd.as of 03 Oct 2024 | 401.60k | 2.03% |
| Nikko Asset Management Co., Ltd.as of 04 Oct 2024 | 357.00k | 1.80% |
| Daiwa Asset Management Co. Ltd.as of 30 Sep 2024 | 184.80k | 0.93% |
| Meiji Yasuda Asset Management Co. Ltd.as of 14 Aug 2023 | 165.00k | 0.83% |
| Asset Management One Co., Ltd.as of 03 Oct 2024 | 134.50k | 0.68% |
| Wellington Management Co. LLPas of 31 Jul 2024 | 76.30k | 0.39% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 03 Oct 2024 | 76.30k | 0.39% |
| Jackson National Asset Management LLCas of 30 Sep 2024 | 51.10k | 0.26% |
| SBI Asset Management Co., Ltd.as of 22 Jun 2023 | 50.50k | 0.26% |
More ▼
Data from 22 Jan 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
